5.77
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLDB?
Forum
Prognose
Aktiensplit
Solid Biosciences Inc Aktie (SLDB) Neueste Nachrichten
Solid Biosciences CEO Cumbo sells $55k in shares - Investing.com
Solid Biosciences: Better Positioned To Compete In DMD Gene Therapy, Says Bullish Analyst - Benzinga
This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Solid Biosciences (SLDB) Receives Buy Rating Amid Competitive Ad - GuruFocus
SLDB Receives "Buy" Rating from Needham with $16 Target Price | SLDB Stock News - GuruFocus
How Solid Biosciences Inc. stock performs in rising dollar environment2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - Newser
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Solid Biosciences (Nasdaq: SLDB) issues 23,284 RSUs under 2024 inducement plan - Stock Titan
Solid Biosciences' SGT-212 Receives Rare Pediatric Disease Designation to Treat Friedreich's Ataxia - MarketScreener
Solid Biosciences (SLDB) Gains Key FDA Designation for Gene Ther - GuruFocus
Solid Biosciences Receives FDA Rare Pediatric Disease and Fast Track Designations for SGT-212, a Novel Gene Therapy for Friedreich’s Ataxia - Quiver Quantitative
Solid Biosciences Inc. Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich's Ataxia - marketscreener.com
Franklin Resources Inc. Has $7.79 Million Position in Solid Biosciences Inc. $SLDB - MarketBeat
Is Solid Biosciences Inc. stock a bargain at current levels2025 Volatility Report & AI Enhanced Trading Alerts - moha.gov.vn
UBS Reaffirms Their Buy Rating on Credit Agricole (0HAI) - The Globe and Mail
SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia - MSN
Solid Biosciences (SLDB) Stock Analysis Report | Financials & Insights - Benzinga
Can Kennametal India Limited Deliver Relative Outperformance to SectorDebt-to-Equity Ratio Analysis & Access Free Tools and Start Investing - earlytimes.in
Is Solid Biosciences Inc a good long term investmentTake Profit Strategies & Free Discover Dynamic Stocks - earlytimes.in
Using Bollinger Bands to evaluate Solid Biosciences Inc.July 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Why Solid Biosciences Inc. stock is trending among retail tradersJuly 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com
How to forecast Solid Biosciences Inc. trends using time seriesGap Up & Weekly Market Pulse Updates - newser.com
What insider trading reveals about Solid Biosciences Inc. stockJuly 2025 Trends & Intraday High Probability Alerts - newser.com
Candlestick signals on Solid Biosciences Inc. stock todayMarket Sentiment Report & Long-Term Safe Investment Plans - newser.com
Strategies to average down on Solid Biosciences Inc.Watch List & Daily Stock Trend Watchlist - newser.com
What MACD signals say about Solid Biosciences Inc.July 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Is Solid Biosciences Inc. stock positioned for long term growth - newser.com
Solid Biosciences licenses next-generation AAV capsid to Andelyn By Investing.com - Investing.com Nigeria
Solid Biosciences stock rises after licensing next-generation capsid By Investing.com - Investing.com Nigeria
Solid Biosciences stock rises after licensing next-generation capsid - Investing.com
Solid Biosciences Grants Capsid AAV-SLB101 License to Andelyn Biosciences - MarketScreener
Andelyn Biosciences Signs Licensing Agreement with Solid Biosciences - Contract Pharma
Solid Biosciences (SLDB) Partners with Andelyn Biosciences for G - GuruFocus
Solid Biosciences licenses next-generation AAV capsid to Andelyn - Investing.com
Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101 - The Manila Times
Solid Biosciences Licenses Next-Generation Capsid AAV-SLB101 to Andelyn Biosciences for Gene Therapy Development - Quiver Quantitative
Solid Biosciences Announces Licensing Agreement With Andelyn Biosciences For The Use Of Proprietary Next-Generation Capsid Aav-Slb101 - TradingView
What’s next for Solid Biosciences Inc. stock priceMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
How sustainable is Solid Biosciences Inc. stock dividend payoutPortfolio Performance Report & Daily Volume Surge Signals - newser.com
What momentum indicators show for Solid Biosciences Inc. stockJuly 2025 Closing Moves & Reliable Volume Spike Trade Alerts - newser.com
Applying sector rotation models to Solid Biosciences Inc.CPI Data & Accurate Technical Buy Alerts - newser.com
Does Solid Biosciences Inc. stock trade at a discount to peers2025 Short Interest & Reliable Momentum Entry Alerts - newser.com
How to monitor Solid Biosciences Inc. with trend dashboards2025 Earnings Impact & Step-by-Step Trade Execution Guides - newser.com
Solid Biosciences director Ganot sells $13,505 in stock By Investing.com - Investing.com India
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):